Literature DB >> 20865786

Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection.

Jorma Toppari1, Helena E Virtanen, Katharina M Main, Niels E Skakkebaek.   

Abstract

Cryptorchidism and hypospadias are common genital birth defects that affect 2-9% and 0.2-1% of male newborns, respectively. The incidence of both defects shows large geographic variation, and in several countries increasing trends have been reported. The conditions share many risk factors, and they are also interlinked to the risk of testis cancer and poor semen quality. Testicular Dysgenesis Syndrome (TDS) may underlie many cases of all these male reproductive health problems. Genetic defects in androgen production or action can cause both cryptorchidism and hypospadias, but these are not common. A monogenic reason for cryptorchidism or hypospadias has been identified only in a small proportion of all cases. Environmental effects appear to play a major role in TDS. Exposure to several persistent chemicals has been found to be associated with the risk of cryptorchidism, and exposure to anti-androgenic phthalates has been shown to be associated with hormonal changes predisposing to male reproductive problems. Despite progress in identification of endocrine-disrupting substances, we are still far from knowing all the risk factors for these birth defects, and advice for prevention must be based on precautionary principles.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865786     DOI: 10.1002/bdra.20707

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  63 in total

Review 1.  Evaluation of the azoospermic male.

Authors:  Robert Oates
Journal:  Asian J Androl       Date:  2011-12-19       Impact factor: 3.285

2.  Endocrine disrupting chemicals: Multiple effects on testicular signaling and spermatogenesis.

Authors:  Bonnie Hy Yeung; Hin T Wan; Alice Ys Law; Chris Kc Wong
Journal:  Spermatogenesis       Date:  2011-07-01

3.  Teasing out the role of aromatase in the healthy and diseased testis.

Authors:  Jenna T Haverfield; Seungmin Ham; Kristy A Brown; Evan R Simpson; Sarah J Meachem
Journal:  Spermatogenesis       Date:  2011-07-01

4.  Decline of semen quality among 10 932 males consulting for couple infertility over a 20-year period in Marseille, France.

Authors:  Cendrine Geoffroy-Siraudin; Anderson Dieudonné Loundou; Fanny Romain; Vincent Achard; Blandine Courbière; Marie-Hélène Perrard; Philippe Durand; Marie-Roberte Guichaoua
Journal:  Asian J Androl       Date:  2012-04-23       Impact factor: 3.285

Review 5.  Cosmetics as endocrine disruptors: are they a health risk?

Authors:  Polyxeni Nicolopoulou-Stamati; Luc Hens; Annie J Sasco
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

6.  In utero exposure to di-(2-ethylhexyl) phthalate induces testicular effects in neonatal rats that are antagonized by genistein cotreatment.

Authors:  Steven Jones; Annie Boisvert; Sade Francois; Liandong Zhang; Martine Culty
Journal:  Biol Reprod       Date:  2015-08-26       Impact factor: 4.285

7.  Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.

Authors:  Russ Hauser; Niels E Skakkebaek; Ulla Hass; Jorma Toppari; Anders Juul; Anna Maria Andersson; Andreas Kortenkamp; Jerrold J Heindel; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2015-03-05       Impact factor: 5.958

Review 8.  Falling sperm counts twenty years on: where are we now?

Authors:  R John Aitken
Journal:  Asian J Androl       Date:  2013-01-28       Impact factor: 3.285

9.  Paediatrics: New cryptorchidism guidelines reach a consensus.

Authors:  Jorma Toppari
Journal:  Nat Rev Urol       Date:  2014-07-29       Impact factor: 14.432

10.  Differential response to abiraterone acetate and di-n-butyl phthalate in an androgen-sensitive human fetal testis xenograft bioassay.

Authors:  Daniel J Spade; Susan J Hall; Camelia M Saffarini; Susan M Huse; Elizabeth V McDonnell; Kim Boekelheide
Journal:  Toxicol Sci       Date:  2013-11-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.